ConductScience.org, home

Paper36733714

E3 ligase ligand optimization of Clinical PROTACs.

Jiang H and 3 others. Front Chem, 2023. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. E3 ligase ligand optimization of Clinical PROTACs. Papers, record 36733714. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36733714

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
E3 ligase ligand optimization of Clinical PROTACs.
PubMed
Journal
Front Chem
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
5.06
iCite
Revised in PubMed
2023-02-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang HHanrui
2Xiong HHuan
3Gu SXShuang-Xi
4Wang MMingliang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131727826Cellular quality control by the ubiquitin-proteasome system and autophagy.Science2019https://conductscience.org/library/papers/31727826PubMed
230510198A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells.Nat Commun2018https://conductscience.org/library/papers/30510198PubMed
318794799Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.Oncogene2008https://conductscience.org/library/papers/18794799PubMed
425856009Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.J Med Chem2016https://conductscience.org/library/papers/25856009PubMed
532888499Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation.Cell Chem Biol2020https://conductscience.org/library/papers/32888499PubMed
630397315A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.Nat Cell Biol2018https://conductscience.org/library/papers/30397315PubMed
732755583Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis.Cell Rep2020https://conductscience.org/library/papers/32755583PubMed
831580635Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins.ACS Chem Biol2019https://conductscience.org/library/papers/31580635PubMed
924355989Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.Nat Rev Mol Cell Biol2014https://conductscience.org/library/papers/24355989PubMed
1034473519Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer.J Med Chem2021https://conductscience.org/library/papers/34473519PubMed
1112001989Death and anti-death: tumour resistance to apoptosis.Nat Rev Cancer2002https://conductscience.org/library/papers/12001989PubMed
1235042991PROTAC targeted protein degraders: the past is prologue.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35042991PubMed
1332332723Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity.Nat Commun2020https://conductscience.org/library/papers/32332723PubMed
1418752944Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics.Bioorg Med Chem Lett2008https://conductscience.org/library/papers/18752944PubMed
1534141084SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.ACS Med Chem Lett2021https://conductscience.org/library/papers/34141084PubMed
166305978Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.J Biol Chem1983https://conductscience.org/library/papers/6305978PubMed
177144906Oncogenes in solid human tumours.Nature1982https://conductscience.org/library/papers/7144906PubMed
1831059647Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.ACS Chem Biol2019https://conductscience.org/library/papers/31059647PubMed
1931804827Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands.J Med Chem2019https://conductscience.org/library/papers/31804827PubMed
2022524316The ubiquitin code.Annu Rev Biochem2012https://conductscience.org/library/papers/22524316PubMed

See all 98 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42977983Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities.Mol Cancer2026https://conductscience.org/library/papers/42977983PubMed
42853260PROTACs in personalized and precision medicine: transforming targeted therapy with advances in selectivity and patient stratification.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42853260PubMed
42446682Coumarin derivatives as HIV-1 inhibitors: mechanistic insights and structure-activity relationships.Med Chem Res2026https://conductscience.org/library/papers/42446682PubMed
42097191Interplay between NRF2 post-translational modifications and protein-protein interactions: Perspectives from emerging structural and functional evidence.Arch Biochem Biophys2026https://conductscience.org/library/papers/42097191PubMed
41935385Contemporary Developments in PROTACs for Cancer Management: An In-Depth Review.Curr Top Med Chem2026https://conductscience.org/library/papers/41935385PubMed
41821623Protacs in oral cancer: degrading oncogenic drivers for next-generation therapy.Front Oral Health2026https://conductscience.org/library/papers/41821623PubMed
41750393Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms.Biomolecules2026https://conductscience.org/library/papers/41750393PubMed
41611823Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation.Commun Chem2026https://conductscience.org/library/papers/41611823PubMed
41221048Molecular docking and dynamics in protein serine/threonine kinase drug discovery: advances, challenges, and future perspectives.Front Pharmacol2025https://conductscience.org/library/papers/41221048PubMed
41208892Role of Ubiquitin-regulated EMT in Cancer Metastasis and Chemoresistance.Int J Biol Sci2025https://conductscience.org/library/papers/41208892PubMed
40885723Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse.Oncogenesis2025https://conductscience.org/library/papers/40885723PubMed
40871058Recent Advances in Nanomedicine: Cutting-Edge Research on Nano-PROTAC Delivery Systems for Cancer Therapy.Pharmaceutics2025https://conductscience.org/library/papers/40871058PubMed
40832528Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library Screen.ACS Med Chem Lett2025https://conductscience.org/library/papers/40832528PubMed
40665123Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders.J Comput Aided Mol Des2025https://conductscience.org/library/papers/40665123PubMed
40624317The changing landscape of medicinal chemistry optimization.Nat Rev Drug Discov2025https://conductscience.org/library/papers/40624317PubMed
40236540Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel-Lindau Tumor Suppressor Protein (VHL).ACS Med Chem Lett2025https://conductscience.org/library/papers/40236540PubMed
40113751The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40113751PubMed
40012379Targeted Management: Unlocking the Crucial Role of PROTACs in Cancer Treatment.Curr Drug Discov Technol2025https://conductscience.org/library/papers/40012379PubMed
39649701Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.Front Mol Biosci2024https://conductscience.org/library/papers/39649701PubMed
39614036Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions.Drug Deliv Transl Res2025https://conductscience.org/library/papers/39614036PubMed

See all 27 cited byDownload CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
BANF18815PubTator's text mininghttps://conductscience.org/library/genes/8815NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BRD965980PubTator's text mininghttps://conductscience.org/library/genes/65980NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
CBL867PubTator's text mininghttps://conductscience.org/library/genes/867NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
CRBN51185PubTator's text mininghttps://conductscience.org/library/genes/51185NCBI Gene
CRLF264109PubTator's text mininghttps://conductscience.org/library/genes/64109NCBI Gene
DDB11642PubTator's text mininghttps://conductscience.org/library/genes/1642NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FEM1B10116PubTator's text mininghttps://conductscience.org/library/genes/10116NCBI Gene
GSPT12935PubTator's text mininghttps://conductscience.org/library/genes/2935NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
IL1R13554PubTator's text mininghttps://conductscience.org/library/genes/3554NCBI Gene
IRAK13654PubTator's text mininghttps://conductscience.org/library/genes/3654NCBI Gene
IRAK451135PubTator's text mininghttps://conductscience.org/library/genes/51135NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36733714

GET https://conductscience.org/api/papers/v1/36733714/references?page=2